- Home
- SANW vs VOR Comparison
SANW vs VOR Comparison
Compare SANW & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANW
- VOR
- Stock Information
- Founded
- SANW 1980
- VOR 2015
- Country
- SANW United States
- VOR United States
- Employees
- SANW N/A
- VOR N/A
- Industry
- SANW Farming/Seeds/Milling
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- SANW Consumer Staples
- VOR Health Care
- Exchange
- SANW Nasdaq
- VOR Nasdaq
- Market Cap
- SANW 11.6M
- VOR 22.1M
- IPO Year
- SANW 2010
- VOR 2021
- Fundamental
- Price
- SANW $5.48
- VOR $0.22
- Analyst Decision
- SANW Strong Buy
- VOR Buy
- Analyst Count
- SANW 1
- VOR 6
- Target Price
- SANW $25.00
- VOR $7.20
- AVG Volume (30 Days)
- SANW 6.3K
- VOR 5.0M
- Earning Date
- SANW 05-15-2025
- VOR 05-14-2025
- Dividend Yield
- SANW N/A
- VOR N/A
- EPS Growth
- SANW N/A
- VOR N/A
- EPS
- SANW N/A
- VOR N/A
- Revenue
- SANW $54,993,808.00
- VOR N/A
- Revenue This Year
- SANW N/A
- VOR N/A
- Revenue Next Year
- SANW $14.25
- VOR N/A
- P/E Ratio
- SANW N/A
- VOR N/A
- Revenue Growth
- SANW 6.91
- VOR N/A
- 52 Week Low
- SANW $2.10
- VOR $0.13
- 52 Week High
- SANW $11.60
- VOR $1.80
- Technical
- Relative Strength Index (RSI)
- SANW 49.38
- VOR 34.09
- Support Level
- SANW $5.36
- VOR $0.22
- Resistance Level
- SANW $5.88
- VOR $0.24
- Average True Range (ATR)
- SANW 0.35
- VOR 0.02
- MACD
- SANW 0.04
- VOR 0.02
- Stochastic Oscillator
- SANW 57.02
- VOR 78.40
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.